Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • VVIP Group Inaugurates Experience Centre and Sales Office in Greater Noida West Business
  • Marketing in 2026 is not broken; the way we measure it is Business
  • Kingston Technology Is with India’s Fight against COVID-19 Business
  • YAAP Digital Announces Leadership Change; Appoints Anjan Roy as Chairman, Managing Director & CEO Business
  • Smarten Power System Limited IPO Opens on July 07, 2025 Business
  • Sathlokhar Synergys E&C Global Limited Wins ₹74.85 Cr (Including GST) EPC Order; FY27 Order Book Stand at ₹1015.18 Cr (Excluding GST) Business
  • Share India Securities Ltd. Reports Stellar Earnings for Q1FY24, PAT Jumps 39% YoY Business
  • Aastha Spintex Stock price up 10% on Rs. 51.46 crore order book for Falcon Yarns Business

Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

Posted on August 30, 2023 By

Company has set a target of achieving Rs. 750 crore revenue by FY26

Ahmedabad (Gujarat) [India], August 30: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has entered the elite league and Rs. 1,000 crore plus market capitalization companies club for the first time. Share price of the company hit a 52 week high of Rs. 513 per share on 28 August 2023 – gain of over 75% in a year’s time. Company aims to maintain healthy growth in revenue and margins in the coming years and has set a target of achieving Rs. 750 crore revenue by FY26 while maintaining its ‘Net Debt Free’ status.

For FY23, the company has reported its Best-ever results in a financial year with highest – Revenue, EBITDA and Net Profit. Company achieved a milestone of Rs. 500 crore plus revenue and Rs. 100 crore plus profit before tax for the first time in a financial year. During Q1FY24 also, company reported an excellent operational and financial performance with Y-o-Y growth of 26.7% in Net Profit, 21.4% growth in EBITDA and 10.3% growth in Total Income.

Company has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started and the company started selling in the domestic markets with product registration under process for many countries for exports. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years.

Company is also ranked among a very few companies to achieve a profit growth every single year from FY13 to FY23. It is among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to do so as per the analysis of Morningstar. During 10 years from FY13 to FY23, Company has delivered a robust CAGR of over 22% in Net profits, 19% plus in EBITDA and over 10% in Revenue.

Financial Performance – Lincoln Pharmaceuticals FY 13 to FY23

Rating agencies, CRISIL has upgraded its ratings on the company’s bank facilities to ‘CRISIL A/Stable and CRISIL A1’. ICRA too has reaffirmed the company’s long-term and short-term bank facilities to A and A1 respectively. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios.

Over the last few years, promoter group have gradually increased their stake in the company. Foreign institutional investors holding as on June 2023 stands at 1.74%. In the last one year, share price of the company has gained by over 75% – from Rs. 283.5 per share on 29 August 2022 to Rs. 4505 per share at close on 28 August 2023.

Company currently exports to 60 plus countries including East & West Africa, Central, North & Latin America and Southeast Asia. Company has recently started exports to Canada. TGA – Australia and EU GMP approvals will further strengthen the company’s presence and expand its network to 90 plus countries.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, TGA, WHO-GMP; ISO-9001:2015, ISO-14001:2015 and ISO-45001:2018. Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has filed 25 plus patent applications and is awarded with seven patents.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Funding Guru Subodh Bajpai Launches his Book Rise and Thrive Unleashing The Entrepreneurial Warrior”
Next Post: CSR Times and Indian Achievers’ Forum host the National Seminar on “Achieving SDG’s through CSR in developing Economies: Role of G20 Nations”

Related Posts

  • Indian Arsheit Dwivedi, 10, a child prodigy with an IQ of 142, among world’s brightest students: Johns Hopkins Business
  • Cressanda Railway Solutions get Contracts for Train Wrap Advertising with Maharashtra Tourism Business
  • Steel Exchange India Limited Announces Stellar Q1 FY27 Performance Business
  • Bright Outdoor Media Spreads Its Wings into Curated Events: Building the Next Growth Engine! Business
  • B. Narasing Rao recognized as The Renaissance Man of our Times Business
  • Huliot Pipes Launch Retail Segment Range Business

Recent Posts

  • Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore
  • Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027
  • India’s DeepTech Capital Needs People Who Can Put It to Work
  • Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput
  • Bench Mark Infotech Services Limited Reports H1 FY27 Results

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Ayurvedic Panchakarma at Parul Ayurved Hospital’s Madhavbaug Unit Supports Patients on Their Cardiac Care Journeys Health
  • Expanding its Footprint, Ampath (American Institute of Pathology & Laboratory Sciences) Launches its 2nd Reference Lab in India Technology
  • Ayurvedic way to heal your excessive white discharge? English
  • DrinkPrime raises ₹60 crores in Series A round led by Omidyar Network India, Surge Sequoia and 9Unicorns Business
  • Vastu Expert Aashesh Agrawaal Guides Hundreds of Families Worldwide Toward Positive Change Business
  • Zaveri and Co.  Celebrates the glamour of Heeramandi with Exquisite New Collection Business
  • USD 1 Billion Business Inquiries Generated at IEEMA’s BID 2024 Business
  • On a mission, with a vision, Meet Shadab Nagani, the man who steered SSIZ International into e-commerce glory Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme